Document is current
Any future updates will be listed below
-
Authors
Ahlmann, Charlotte
Madden, Iona https://orcid.org/0000-0001-8679-0960
Busjahn, Andreas
Panagiotopoulou, Olga
Azukaitis, Karolis
Bakkaloglu, Sevcan A.
Ağbaş, Ayşe
Anarat, Ali
Askiti, Varvara
Bayazit, Aysun K.
Bulut, Ipek Kaplan
Canpolat, Nur
Borzych-Duzalka, Dagmara
Duzova, Ali
Habbig, Sandra
Krid, Saoussen
Licht, Christoph
Litwin, Mieczyslaw
Obrycki, Lukasz
Paglialonga, Fabio
Ranchin, Bruno
Samaille, Charlotte
Shenoy, Mohan
Sinha, Manish D.
Spasojevic, Brankica
Stronach, Lynsey
Vidal, Enrico
Yilmaz, Alev
Fischbach, Michel
Schaefer, Franz
Schmitt, Claus Peter
Oh, Jun
Hothi, Daljit
Shroff, Rukshana
-
Funding
Funding for this research was provided by:
Fresenius Medical Care Deutschland GmbH
- License Information
-
More Information
Article History
Received: 7 April 2025
Revised: 23 June 2025
Accepted: 23 July 2025
First Online: 12 August 2025
Declarations
:
: RS has received research grants from Fresenius Medical Care, is on the Scientific Advisory Board of Fresenius Medical Care, and has received speaker honoraria from Fresenius Medical Care, Amgen, Vitaflo, Triomed and Humacyte. CPS has received consulting fees from Chiesi, Baxter, StadaPharma and Bioporto; lecture honorarium and travel support from Chiesi; and research funding from Invizius and Baxter. JO has received research funding from Fresenius Medical Care and received honoraria for his role in advisory board meetings from Astra Zeneca. CA, IM, AB, OP, KA, SB, AA, AA, VA, AB, IB, NC, DBD, AD, SH, SK, CL, ML, LO, FP, BR, CS, MS, MDS, BS, LS, EV, AY, MF, FS and DH have no relevant financial or non-financial interests to disclose.The 3H study was sponsored by Kidney Research UK. Part sponsorship was obtained from Fresenius Medical Care, who approved the study protocol, but had no role in data collection, data analysis or drafting the present manuscript.
